These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26324025)

  • 41. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
    Tan W; Lim SG; Tan TM
    World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells.
    Zhou P; Huang G; Zhao Y; Zhong D; Xu Z; Zeng Y; Zhang Y; Li S; He F
    Cell Signal; 2014 Jun; 26(6):1347-54. PubMed ID: 24631531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer.
    Kiga K; Fukuda-Yuzawa Y; Tanabe M; Tsuji S; Sasakawa C; Fukao T
    RNA Biol; 2014; 11(11):1347-54. PubMed ID: 25483038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
    Zhuang LK; Yang YT; Ma X; Han B; Wang ZS; Zhao QY; Wu LQ; Qu ZQ
    Cell Death Dis; 2016 Apr; 7(4):e2203. PubMed ID: 27100897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
    Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
    J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1.
    Li Y; Zhu W; Li J; Liu M; Wei M
    Oncol Rep; 2013 Dec; 30(6):2820-8. PubMed ID: 24064760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
    Zhang Y; Zheng D; Xiong Y; Xue C; Chen G; Yan B; Ye Q
    FEBS Lett; 2014 May; 588(10):1913-20. PubMed ID: 24704686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma.
    Yang DH; Huang W; Cui J; Shu JC; Tang SH; Zhang WJ; Liang JH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):86-9. PubMed ID: 14969845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Fragment HMGA2-sh-3p20 from HMGA2 mRNA 3'UTR Promotes the Growth of Hepatoma Cells by Upregulating HMGA2.
    Wang Y; Chen F; Yang Z; Zhao M; Zhang S; Gao Y; Feng J; Yang G; Zhang W; Ye L; Zhang X
    Sci Rep; 2017 May; 7(1):2070. PubMed ID: 28522832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of the human astrocyte elevated gene-1 promoter variants with susceptibility to hepatocellular carcinoma.
    Motalleb G; Gholipour N; Samaei NM
    Med Oncol; 2014 Apr; 31(4):916. PubMed ID: 24659263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural antisense transcript of MYOG regulates development and regeneration in skeletal muscle by shielding the binding sites of MicroRNAs of MYOG mRNA 3'UTR.
    Yin Y; Chen G; Lin Z; Zhang D; Lin W; Luo W
    Biochem Biophys Res Commun; 2023 Jun; 662():93-103. PubMed ID: 37104884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NF90 regulates PARP1 mRNA stability in hepatocellular carcinoma.
    Song D; Huang H; Wang J; Zhao Y; Hu X; He F; Yu L; Wu J
    Biochem Biophys Res Commun; 2017 Jun; 488(1):211-217. PubMed ID: 28487110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of cytoskeletal-associated protein tyrosine phosphatase PTPH1 mRNA in human hepatocellular carcinoma.
    Ikuta S; Itoh F; Hinoda Y; Toyota M; Makiguchi Y; Imai K; Yachi A
    J Gastroenterol; 1994 Dec; 29(6):727-32. PubMed ID: 7874267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sirt1 Antisense Long Noncoding RNA Promotes Cardiomyocyte Proliferation by Enhancing the Stability of Sirt1.
    Li B; Hu Y; Li X; Jin G; Chen X; Chen G; Chen Y; Huang S; Liao W; Liao Y; Teng Z; Bin J
    J Am Heart Assoc; 2018 Nov; 7(21):e009700. PubMed ID: 30608184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rs2015 Polymorphism in miRNA Target Site of Sirtuin2 Gene Is Associated with the Risk of Parkinson's Disease in Chinese Han Population.
    Chen X; Mai H; Chen X; Cai Y; Cheng Q; Chen X; Li X; Fan W; Tang P; Ou M; Yang J; Chen Y; Cui L
    Biomed Res Int; 2019; 2019():1498034. PubMed ID: 31214610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miRNA‑384‑5p regulates the progression of Parkinson's disease by targeting SIRT1 in mice and SH‑SY5Y cell.
    Tao H; Liu Y; Hou Y
    Int J Mol Med; 2020 Feb; 45(2):441-450. PubMed ID: 31894288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic Identification of RNA Editing Through Integrating Omics Datasets and the Clinical Relevance in Hepatocellular Carcinoma.
    Chen J; Wang L; Wang F; Liu J; Bai Z
    Front Oncol; 2020; 10():37. PubMed ID: 32117713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma.
    Farcas M; Gavrea AA; Gulei D; Ionescu C; Irimie A; Catana CS; Berindan-Neagoe I
    Front Nutr; 2019; 6():148. PubMed ID: 31608282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.